Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer Vaccine
RedChip Companies will host an investor webinar on Tuesday, October 20, 2026, at 4:15 p.m. ET with Anixa Biosciences, Inc. (Nasdaq:ANIX), a clinical-stage biotechnology company developing first-in-class therapies to treat and potentially prevent cancer. The exclusive event will feature Dr. Amit Kumar, Chairman and CEO, who will discuss Anixa's two clinical-stage oncology programs: lira-cel, a novel CAR-T therapy for recurrent,...
Read more








